BaileyI.Sir William Osler (1849–1919): physician, teacher, historian, biographer, bibliophile. J Med Biog1993; 1: 2–10
2.
StoneMJ. The wisdom of Sir William Osler. Am J Cardiol1995; 75: 269–76
3.
OslerW.The Principles and Practice of Medicine. New York: Appleton, 1892
4.
BlissM.William Osler. A Life in Medicine. Oxford: Oxford University Press, 1999
5.
CushingH.The Life of Sir William Osler (2 vols). Oxford: Clarendon Press, 1925
6.
Robb-SmithAHT. Osler's influence on haematology. Blood Cells1981; 7: 513–33
7.
OslerW.Cartwright lectures: On certain problems in the physiology of the blood corpuscles. Medical News, 3 April 1886: 1017
8.
Robb-SmithAHT. Why the platelets were discovered. Brit J Haematol1967; 13: 618–37
9.
CoarT.The Aphorisms of Hippocrates: With a Translation into Latin, and English. London: AJ Valpy, 1822 (Classics of Medicine Library edition, Birmingham, Alabama, 1982)
10.
RosnerFMuntnerS.The Medical Aphorisms of Moses Maimonides. New York: Bloch, 1971: vol. II, p. 127
11.
MajorRH. Classic Descriptions of Disease (2nd edn). Springfield: Charles C Thomas, 1939: 419–21
12.
VaquezH.Sur une forme spéciale de cyanose s'accompanant d'hyperglobulie excessive et peristente. Compt rend Soc de biol1892; 4: 384–8 and suppl. note, Bull et mém Soc méd d'hôp de Paris, 3 ser., 1895; 12: 60
13.
OslerW.Chronic cyanosis with polycythaemia and enlarged spleen: a new clinical entity. Am J Med Sci.1903; 126: 187–201
14.
OslerW.Chronic cyanotic polycythaemia with enlarged spleen. BMJ1904; i: 121–2
15.
OslerW.A clinical lecture on erythraemia (polycythaemia with cyanosis, maladie de Vaquez). Lancet1908; i: 143–6
WintrobeMM. Milestones on the path of progress. In: WintrobeMM, Ed. Blood, Pure and Eloquent. New York: McGraw-Hill, 1980: 1–31
28.
HoffbrandAVFantiniB.Achievements in hematology in the twentieth century: an introduction. Semin Hematol1999; 36 (suppl. 7): 1–4
29.
WassermanLRGilbertHS. Surgery in polycythemia vera. N Engl J Med.1963; 269: 1226–30
30.
WeinsteinIM. Clinical manifestations. In: KleinH, Ed. Polycythemia Theory and Management. Springfield: Charles C Thomas, 1973: 95
31.
SilvaMRichardCBenitoASanzCOlallaIFernandez-LunaJL. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N Engl J Med.1998; 338: 564–71
32.
MoliternoARHawkinsWDSpivakJL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med.1998; 338: 572–80
33.
SchwartzRS. Polycythemia vera — chance, death, and mutability. N Engl J Med.1998; 338: 613–15
34.
SpivakJC. Polycythemia vera and other myeloproliferative diseases. In: FauciASBraunwaldEIsselbacherKJ, eds. Harrison's Principles of Internal Medicine (14th edn). New York: McGraw-Hill, 1998: 679–81
35.
MeansRT. Polycythemia vera. In: LeeGRFoersterJLukensJParaskevasFGreerJPRodgersGM, Eds. Wintrobe's Clinical Hematology (10th edn). Baltimore: Williams & Wilkins, 1999: vol. 2, pp. 2374–89
36.
McKusickVA. On the naming of clinical disorders, with particular reference to eponyms. Medicine1998; 77: 1–2
37.
BeanRBBeanWB, Eds. Sir William Osler. Aphorisms from His Bedside Teachings and Writings (2nd printing). Springfield: Charles C Thomas, 1961: 112
